humor
innat
immun
respons
consist
multipl
compon
includ
natur
occur
antibodi
nab
pentraxin
complement
contact
cascad
solubl
plasma
compon
innat
protein
provid
key
element
prevent
control
diseas
howev
pathogen
cell
alter
self
protein
util
multipl
humor
compon
evad
destruct
promot
pathogi
mani
studi
examin
relationship
humor
immun
autoimmun
disord
review
focus
interact
humor
compon
role
promot
pathogenesi
bacteri
viral
infect
chronic
diseas
atherosclerosi
cancer
understand
benefici
detriment
aspect
individu
compon
interact
protein
regul
innat
adapt
respons
provid
therapeut
target
subsequ
studi
first
line
defens
innat
immun
respons
consist
cellular
humor
compon
cellular
compon
encompass
multipl
cell
type
use
pattern
recognit
molecul
recogn
remov
pathogen
cellular
debri
interact
pattern
recognit
molecul
within
cellular
compon
receiv
signific
attent
last
two
decad
contrast
less
known
interact
humor
compon
humor
innat
immun
respons
consist
serin
proteas
cascad
complement
contact
system
well
natur
occur
antibodi
nab
pentraxin
recent
data
indic
compon
may
benefici
detriment
infect
chronic
diseas
depend
concentr
interact
compon
review
focu
interact
role
humor
compon
bacteri
viral
infect
well
chronic
diseas
atherosclerosi
cancer
complement
activ
occur
one
three
initi
pathway
classic
altern
mannos
bind
lectin
mbl
pathway
pathway
contain
convertas
cleav
produc
subsequ
convertas
cleavag
convertas
result
deposit
initi
common
termin
pathway
termin
pathway
form
membran
attack
complex
mac
pore
cellular
membran
lysi
host
pathogen
cell
action
convertas
also
produc
potent
anaphylatoxin
although
specif
part
humor
immun
respons
complement
receptor
found
neutrophil
macrophag
enhanc
innat
immun
respons
recogn
opson
pathogen
recent
evid
indic
complement
play
signific
role
direct
adapt
immun
respons
well
tissu
regener
specif
part
b
cell
receptor
complex
recognit
cleavag
product
significantli
increas
ab
product
thu
maintain
homeostasi
requir
tight
regul
cascad
regul
potenti
damag
cascad
occur
multipl
level
solubl
membran
bound
inhibitor
includ
inhibitor
factor
h
relat
protein
plasma
also
contain
compon
second
proteolyt
cascad
contact
system
factor
xii
fxii
hageman
factor
contact
system
proteolyt
cleav
fxiia
neg
charg
surfac
damag
cell
fxiia
initi
coagul
cascad
lead
clot
format
cleav
prekallikrein
kallikrein
subsequ
releas
bradykinin
endotheli
gcoupl
receptor
bradykinin
receptor
bradykinin
induc
vasodil
neutrophil
chemotaxi
vascular
permeabl
furthermor
bradykinin
degrad
product
regul
adapt
respons
alter
bloodbrain
barrier
second
receptor
bradykinin
receptor
importantli
fxiia
kallikrein
activ
complement
cascad
independ
known
complement
initi
sever
compon
activ
contact
system
includ
fxa
fxia
plasmin
cleav
produc
complement
inhibitor
also
inhibit
fxiia
indic
multipl
interact
two
pathway
data
suggest
crosstalk
two
cascad
humor
innat
immun
respons
produc
primarili
b
lymphocyt
nab
germlineencod
ab
restrict
epitop
specif
produc
absenc
extern
antigen
stimul
nab
usual
igm
isotyp
may
includ
igg
iga
isotyp
well
natur
igm
ab
mediat
clearanc
cellular
debri
age
apoptot
cell
opon
recruit
complement
compon
part
innat
immun
respons
nab
recogn
wide
rang
pathogen
albeit
low
affin
modul
adapt
immun
respons
interact
b
dendrit
cell
final
nab
potent
initi
complement
cascad
suggest
addit
interact
compon
innat
humor
respons
famili
evolutionarili
conserv
multimer
pattern
recognit
protein
pentraxin
acut
phase
protein
rapidli
synthes
serv
marker
infect
inflamm
tissu
damag
pentraxin
contain
common
domain
c
terminu
presenc
absenc
addit
domain
divid
famili
long
short
pentraxin
respect
short
pentraxin
includ
creactiv
protein
crp
serum
amyloid
p
protein
sap
produc
liver
produc
multitud
cell
type
pentraxin
primari
long
pentraxin
activ
humor
innat
immun
similar
nab
pentraxin
recogn
bind
multipl
pathogen
well
intrins
ligand
includ
apoptot
cell
extracellular
matrix
compon
macrophag
innat
immun
cell
recogn
pentraxin
crp
sap
via
receptor
bind
pentraxin
target
facilit
clearanc
pathogen
cell
debri
complement
activ
indic
addit
interact
compon
innat
immun
respons
overal
pentraxin
multifunct
nonredund
compon
humor
innat
immun
respons
therefor
pentraxin
play
critic
role
human
diseas
interact
multipl
compon
humor
respons
togeth
interact
compon
humor
arm
innat
immun
respons
critic
protect
host
invad
pathogen
interact
cellular
compon
instruct
adapt
immun
respons
howev
inappropri
activ
one
humor
compon
may
detriment
host
review
focus
infecti
organ
evad
devast
circul
protein
chronic
diseas
may
enhanc
interact
nab
pentraxin
complement
contact
cascad
coordin
attack
multipl
compon
humor
innat
immun
system
crucial
protect
host
bacteri
infect
compromis
humor
innat
immun
system
increas
suscept
bacteria
success
develop
therapeut
decreas
bacteri
infect
requir
understand
interact
complement
contact
cascad
well
nab
pentraxin
complement
contribut
humor
innat
immun
respons
directli
mac
complex
form
pore
lyse
bacteria
well
indirectli
activ
compon
immun
system
combat
bacteria
invad
bacteria
induc
complement
activ
three
initi
pathway
nab
recogn
invad
bacteria
activ
classic
mbl
complement
pathway
mbl
pathway
also
recogn
sugar
moieti
bacteri
surfac
addit
presenc
bacteri
carbohydr
lipid
protein
trigger
altern
complement
pathway
activ
three
pathway
result
cleavag
coat
bacteri
surfac
enhanc
recognit
neutrophil
macrophag
opson
coat
bacteria
also
bind
enhanc
ab
product
initi
pathway
may
also
result
bacteri
lysi
mac
although
activ
complement
cascad
essenti
immun
protect
bacteria
evolv
sever
strategi
evad
immun
respons
evas
strategi
bacteria
broadli
classifi
four
type
recruit
mimick
complement
regul
b
inhibit
modul
complement
protein
c
enzymat
degrad
complement
protein
blockag
mac
penetr
exampl
enterococcu
faecali
streptococcu
pyogen
gram
posit
bacteria
endow
thick
polysaccharid
capsul
prevent
complet
penetr
capsul
cell
wall
mac
subsequ
bacteri
lysi
mani
bacteria
evad
complement
recruit
complement
regulatori
protein
bacteri
surfac
prevent
lysi
specif
exampl
provid
tabl
sever
import
pathogen
includ
pyogen
streptococcu
pneumonia
neisseria
gonorrohea
borrelia
burgdorferi
produc
protein
recruit
factor
h
altern
pathway
andor
classic
lectin
pathway
bacteria
produc
protein
directli
interact
inhibit
central
complement
compon
exampl
pneumonia
protein
pspa
inhibit
deposit
pneumococc
surfac
similarli
bacteri
protein
directli
inhibit
convertas
mac
format
addit
bacteri
enzym
degrad
critic
complement
compon
includ
anaphylatoxin
prevent
chemotaxi
phagocyt
cell
toward
site
infect
e
faecali
lead
nosocomi
pathogen
produc
gelatinas
enzym
directli
cleav
prevent
neutrophil
recruit
site
infect
due
incomplet
complement
activ
mechan
frequent
allow
bacteri
prolifer
deleteri
effect
host
better
understand
bacteri
protein
inhibit
complement
activ
may
lead
therapeut
also
curb
excess
complement
activ
although
contact
cascad
may
activ
complement
bacteri
lysi
contact
activ
directli
surfac
bacteria
also
elimin
invad
bacteria
complement
independ
manner
bacteri
activ
contact
system
releas
kinin
turn
lead
product
potent
antimicrobi
peptid
recruit
immun
compon
site
infect
despit
activ
immun
respons
kinin
releas
subsequ
vasodil
may
favor
bacteria
due
influx
plasma
nutrient
site
infect
increas
microcircul
bacteria
massiv
activ
contact
system
also
caus
excess
consumpt
thrombin
result
hypovolem
shock
sepsisinduc
coagul
bacteria
initi
contact
cascad
induc
kinin
releas
produc
proteas
degrad
kininogen
b
activ
fxii
c
use
structur
element
surfac
protein
activ
contact
cascad
sever
pathogen
includ
porphyromona
gingivali
staphylococcu
aureu
pyogen
produc
protein
degrad
kininogen
kinin
without
releas
bradykinin
expect
excess
kinin
releas
result
array
patholog
complic
host
bacteria
produc
proteas
activ
fxii
produc
kinin
exampl
alkalin
proteinas
elastas
produc
pseudomona
spp
vibrio
proteinas
produc
vibrio
vulnificu
proteinas
produc
aureu
activ
fxii
mani
structur
element
bacteri
surfac
includ
lipopolysaccharid
gram
neg
bacteria
lipoteicho
gram
posit
bacteria
activ
contact
system
surfac
protein
pathogen
protein
pyogen
curli
fiber
escherichia
coli
salmonella
typhii
also
bind
contact
system
compon
initi
releas
bradykinin
recent
evid
suggest
patient
sever
sepsi
abnorm
high
level
kinin
increas
express
bradykinin
receptor
bind
bradykinin
receptor
caus
massiv
proinflammatori
respons
often
detriment
host
key
particip
humor
innat
immun
respons
nab
specif
pathogen
bacteria
exist
sera
uninfect
individu
play
critic
role
earli
clearanc
invad
bacteria
activ
complement
saliva
contain
secretoryiga
recogn
clear
pyogen
other
demonstr
nab
titer
increas
bacteri
load
pseudomona
spp
infect
correl
bacteri
elimin
n
gonorrhoea
induc
nab
igm
igg
iga
isotyp
recogn
heatstabl
heatlabil
bacteri
antigen
contrast
immun
ab
recogn
heatstabl
heatlabil
antigen
mani
nab
recogn
commens
includ
enter
e
coli
salmonella
typhosai
presenc
nab
prevent
overgrowth
enter
gut
microbiota
similarli
nab
mediat
protect
respiratori
pathogen
pneumonia
earli
respiratori
tract
colon
infant
pneumococc
antigen
may
stimul
product
ab
nab
keep
commens
check
also
play
crucial
role
prevent
dissemin
intracellular
bacteria
exampl
nab
enhanc
antigentrap
listeria
monocytogen
secondari
lymphoid
organ
although
nab
extrem
effect
initi
earli
respons
invad
bacteria
report
earli
indic
nab
concentr
decreas
sever
bacteri
sepsi
late
sepsi
bacteri
burden
surpass
specif
threshold
plasma
nab
concentr
plummet
due
larg
number
antigenab
complex
togeth
complex
bacteri
endotoxin
increas
permeabl
capillari
allow
reticuloendotheli
system
rapidli
clear
ab
complex
clinic
biomark
infect
concentr
crp
pentraxin
increas
within
hr
post
infect
increas
level
appear
produc
human
monocyt
macrophag
dendrit
cell
respons
whole
bacteria
bacteri
cell
wall
compon
exampl
pseudomona
aeruginosa
mycobacterium
bovi
bacil
calmetteguerin
stimul
product
addit
mycobacteri
cell
wall
compon
lipoarabinomannan
lipopolysaccharid
stimul
express
human
peripher
mononuclear
cell
contrast
crp
produc
respons
neisseria
meningitid
opson
bacteria
enhanc
phagocytosi
macrophag
recent
studi
demonstr
recogn
pentraxin
bound
pathogen
surfac
target
bacteria
destruct
pentraxinbacteri
interact
may
also
exist
thu
addit
studi
examin
complex
interact
bacteria
pentraxin
enhanc
understand
hostbacteria
interact
togeth
compon
humor
innat
immun
system
play
indispens
role
remov
bacteria
host
nab
contact
system
pentraxin
aid
elimin
bacteria
activ
complement
system
lyse
addit
bacteria
howev
bacteria
evolv
sever
escap
mechan
may
use
host
addit
bacteri
complement
inhibitor
may
use
treatment
diseas
involv
excess
complement
activ
understand
complex
interact
bacteria
humor
innat
immun
respons
crucial
design
effect
therapeut
intervent
bacteri
infect
compon
humor
immun
mediat
innat
adapt
immun
respons
complement
directli
neutral
virus
modul
pathogen
elimin
fig
mbl
directli
bind
multipl
viral
glycoprotein
includ
hiv
sar
coronaviru
marburg
viru
addit
glycoprotein
bind
enhanc
humor
immun
respons
similar
fashion
recogn
cleavag
product
lower
threshold
b
cell
activ
importantli
contribut
normal
antivir
igm
igg
respons
modul
humor
immun
indic
crucial
role
complement
activ
immun
respons
virus
virus
use
differ
mechan
counter
disrupt
care
regul
complement
cascad
enzym
protein
complex
receptor
virus
evad
host
immun
respons
modifi
b
enter
host
cell
c
use
host
viral
produc
complement
inhibitor
prevent
cell
lysi
viral
protein
directli
interact
compon
complement
cascad
disrupt
complementmedi
destruct
frequent
target
viral
protein
exampl
coat
protein
human
astroviru
type
bind
displac
tetram
inhibit
activ
classic
complement
pathway
similarli
matrix
protein
influenza
viru
bind
viral
protein
block
interact
igg
mani
virus
modul
central
compon
complement
cascad
west
nile
viru
synthes
two
isoform
protein
regul
solubl
increas
factor
imedi
cleavag
cell
surfacebound
decreas
deposit
mac
herp
viru
synthes
transmembran
glycoprotein
bind
specif
acceler
decay
altern
convertas
inhibit
interact
properdin
togeth
studi
indic
virus
interact
multipl
complement
compon
prevent
complementmedi
host
cell
death
thu
complement
inhibitor
either
host
viral
synthes
protect
infect
cell
lysi
allow
viru
prolifer
virus
induc
complement
activ
benefit
hiv
enter
human
cell
complement
receptor
hiv
protein
activ
complement
classic
lectin
pathway
respect
time
two
protein
inhibit
mac
format
recruit
factor
h
surfac
virallyinfect
host
cell
abolish
complementmedi
lysi
therefor
complement
aid
viral
entri
viru
prevent
cell
lysi
inhibit
remaind
complement
cascad
activ
contact
cascad
recent
studi
show
herp
simplex
viru
hsv
hcmv
hanta
viru
enhanc
thrombin
format
fibrinolysi
hsv
glycoprotein
bind
factor
x
induc
gener
thrombin
hsv
infect
also
decreas
endotheli
heparin
sulfat
proteoglycan
hspg
recruit
bind
antithrombin
iii
virus
includ
dengu
viru
hiv
also
associ
decreas
thrombin
gener
dengu
viru
produc
nonstructur
protein
bind
inhibit
prothrombin
activ
virus
abl
modul
cytokin
express
induc
procoagul
state
mediat
marburg
viru
ebola
viru
hanta
viru
induc
tissu
factor
express
endotheli
surfac
virus
also
take
advantag
coagul
factor
enhanc
viral
bind
replic
human
speci
bind
coagul
factor
ix
facilit
viru
entri
infect
human
adenovirus
util
coagul
factor
x
infect
host
cell
sindbi
virus
upregul
express
receptor
endotheli
cell
subsequ
enhanc
viral
replic
reduc
sindbi
virusinduc
apoptosi
depend
manner
thu
virus
also
modul
contact
cascad
thrombin
activ
promot
viral
infect
broad
reactiv
individu
nab
allow
rapid
recognit
protect
pathogen
never
encount
bridg
innat
adapt
immun
respons
pentraxin
superfamili
multimer
protein
respond
varieti
inflammatori
stimuli
activ
complement
prevent
infect
describ
earlier
classic
short
pentraxin
crp
sap
gener
accept
indic
infect
similar
bacteria
prototyp
long
pentraxin
rapidli
increas
respons
viral
infect
better
protein
marker
dengu
viru
infect
crp
also
demonstr
antivir
function
human
murin
cytomegaloviru
hcmv
mcmv
influenza
viru
studi
bind
virus
inhibit
viralcel
fusion
intern
influenza
infect
sialyl
ligand
mimic
structur
cellular
receptor
bind
viral
hemagglutinin
glycoprotein
block
receptorbind
site
hemagglutinin
thu
pentraxin
recogn
bind
viral
antigen
initi
humor
innat
immun
respons
howev
specif
role
pentraxin
viral
infect
well
studi
part
humor
innat
immun
complement
contact
system
nab
pentraxin
work
togeth
develop
elabor
network
cascad
respons
viral
infect
although
humor
innat
immun
respons
critic
prevent
bacteri
viral
infect
compon
frequent
pathogen
chronic
diseas
exampl
complement
play
key
role
pathogenesi
atherosclerosi
compar
nonatherosclerot
arteri
fibrou
plaqu
upregul
transcript
classic
complement
cascad
protein
addit
deposit
classic
complement
protein
includ
mac
occur
atherosclerosi
altern
complement
pathway
also
implic
plaqu
develop
atherogenesi
exampl
plasma
mice
highfat
dietinduc
atherosclerot
lesion
contain
elev
properdin
factor
level
endotoxinand
dietinduc
atherosclerosi
ldl
receptordefici
mice
also
requir
altern
pathway
factor
b
importantli
defici
protect
dietinduc
atherosclerosi
indic
termin
complement
pathway
requir
progress
atherosclerot
lesion
inde
mac
deposit
correl
sever
arteri
damag
human
aortic
fibrou
plaqu
mice
mac
deposit
promot
endotheli
damag
endotheli
mac
deposit
also
preced
monocyt
infiltr
foam
cell
format
rabbit
model
atherosclerosi
togeth
data
indic
multipl
complement
pathway
activ
increas
risk
atherosclerosi
complement
regulatori
protein
maintain
balanc
complement
activ
inhibit
lewi
et
al
found
mac
contribut
atherogenesi
although
nab
activ
complement
ab
also
aid
clearanc
proatherogen
debri
fig
nab
recogn
proinflammatori
oxidationspecif
epitop
associ
oxid
stress
apoptosi
atherosclerosi
recent
chang
et
al
report
oxid
phospholipid
specif
nab
clone
attenu
endotheli
activ
subsequ
atherogenesi
vitro
studi
indic
igm
nab
recogn
malondialdehyd
malondialdehyd
low
densiti
lipoprotein
ldl
oxid
ldl
recognit
oxid
ldl
prevent
macrophag
uptak
inhibit
foam
cell
format
atherogenesi
howev
condit
myocardi
infarct
nab
patholog
compar
wildtyp
mice
ab
defici
mice
experi
significantli
less
tissu
damag
respons
myocardi
infarct
importantli
administ
singl
nab
clone
restor
tissu
damag
inflamm
ab
defici
mice
addit
peptid
inhibit
nab
bind
attenu
myocardi
infarct
induc
injuri
wildtyp
mice
nab
play
key
role
modul
atherosclerosi
clear
apoptot
cell
oxid
structur
howev
excess
complement
activ
respons
nab
bind
may
detriment
caus
patholog
complement
intim
relationship
contact
system
suggest
mani
coagul
factor
also
play
key
role
develop
atherosclerosi
increas
cardiovascular
diseas
risk
atherosclerot
vascular
damag
associ
elev
level
factor
xii
prekallikrein
high
molecular
weight
kininogen
factor
xi
addit
factor
xii
mice
protect
arteri
thrombosi
stroke
indic
activ
contact
system
howev
specif
crosstalk
contact
complement
system
atherosclerosi
still
poorli
understood
address
futur
investig
well
establish
pentraxin
activ
complement
cascad
atherosclerosi
recent
research
demonstr
pentraxin
may
direct
role
induc
atherosclerosi
fig
pentraxin
deposit
atherosclerot
plaqu
interact
enzymat
modifi
oxid
lipoprotein
promot
foam
cell
format
induc
endotheli
cell
dysfunct
exacerb
atherosclerosi
although
controversi
crp
appear
play
role
atherosclerosi
detect
arteri
wall
earli
stage
atherogenesi
crp
continu
accumul
diseas
progress
inhibit
endotheli
product
nitric
oxid
crp
impair
vasodil
angiogenesi
facilit
endotheli
cell
apoptosi
lead
atherosclerot
lesion
format
addit
increas
express
activ
endotheli
cell
plasminogen
activ
fibrinolysi
inhibitor
crp
potenti
contribut
plaqu
instabl
atherothrombosi
crp
also
enhanc
endotheli
cell
adhes
molecul
superoxid
product
promot
monocyt
recruit
plaqu
may
contribut
atherogenesi
crp
also
bind
enzymat
modifi
oxid
ldl
howev
benefici
natur
bind
remain
controversi
clinic
set
metaanalysi
larg
multin
statin
trial
found
increas
crp
level
identifi
limit
popul
risk
clinic
outcom
thu
addit
clinic
studi
requir
prior
increas
crp
screen
popul
similar
nab
crp
also
implic
myocardi
infarct
complementdepend
manner
earli
studi
indic
crp
activ
classic
complement
pathway
monomer
crp
bind
altern
complement
pathway
inhibitor
factor
h
review
mold
addit
pentraxin
also
play
role
atherosclerosi
sap
also
detect
human
atherosclerot
lesion
bind
serum
amyloid
compon
saa
sap
mediat
inflammatori
respons
amyloid
fibril
atherosclerosi
contrast
sap
bind
prevent
uptak
oxldl
macrophag
possibl
reduc
foam
cell
format
similar
crp
sap
elev
express
preced
atherosclerot
lesion
develop
correl
acut
myocardi
infarct
increas
tissu
factor
express
endotheli
cell
potenti
induc
atherothrombosi
togeth
result
indic
causal
role
pentraxin
atherogenesi
suggest
may
effect
therapeut
target
atherosclerosi
conclus
patholog
atherosclerosi
complex
multifactori
process
involv
lipid
deposit
vessel
wall
dysfunct
inflamm
autoimmun
humor
innat
immun
compon
play
pivot
role
progress
chronic
diseas
activ
compon
may
drive
atherogenesi
wherea
nab
may
also
protect
atherosclerosi
bind
oxidationspecif
epitop
note
compon
act
independ
interact
collect
modul
diseas
progress
research
warrant
examin
integr
role
humor
innat
immun
compon
atherosclerosi
insight
may
yield
new
understand
mechan
underli
diseas
lead
novel
therapeut
approach
attenu
progress
atherosclerosi
complement
product
mac
detect
tumor
microenviron
activ
complement
protein
three
mechan
complementmedi
destruct
tumor
cell
complementdepend
cytotox
cdc
b
indirect
abdepend
cellmedi
cytotox
complement
receptordepend
c
cellular
cytotox
rel
rare
tumor
complement
compon
deposit
variou
tumor
type
indic
activ
complement
may
contribut
immunosurveil
malign
cell
complement
protein
deposit
cellular
surfac
breast
cancer
cell
papillari
thyroid
carcinoma
cell
complement
activ
product
cleavag
product
detect
ovarian
carcinoma
patient
complement
activ
deposit
neoplast
tissu
function
implic
unclear
tumor
cell
resist
complement
mediat
attack
tumor
cell
natur
mechan
selfprotect
complement
system
specif
mac
cytotox
activ
extracellular
protector
membran
solubl
complement
inhibitor
releas
tumor
cell
microenviron
interfer
complement
cascad
activ
limit
quantiti
complement
deposit
membran
complement
inhibitor
includ
mcp
daf
control
activ
complement
level
serv
import
mechan
selfprotect
make
cell
insensit
action
complement
although
complement
system
regul
inflamm
innat
immun
respons
complement
protein
also
aid
tumor
growth
immunosuppress
exampl
mice
display
signific
decreas
tumor
prolifer
compar
wildtyp
mice
result
may
link
anaphylatoxin
particip
sever
signal
transduct
pathway
link
tumorigenesi
fig
bind
receptor
increas
induc
transcript
chang
cell
cycl
progress
inhibit
apoptosi
specif
receptor
receptor
activ
mapk
erk
phosphatidylinosityol
akt
signal
transduct
pathway
may
mediat
oncogen
transform
progress
similar
pathway
may
also
activ
mac
induc
cellular
prolifer
thu
complement
protein
promot
tumor
growth
upregul
signal
molecul
cellular
prolifer
prevent
apoptosi
neoplast
cell
complement
anaphylatoxin
may
alter
cellular
differenti
result
immun
suppress
healthi
individu
myeloidderiv
suppressor
md
cell
differenti
macrophag
dendrit
cell
neutrophil
howev
trap
intermedi
stage
differenti
md
cell
may
mediat
tumorinduc
immun
suppress
tumor
secret
factor
induc
proinflammatori
mediat
recruit
md
tumor
cell
disrupt
normal
differenti
md
cell
fig
bind
md
increas
reactiv
oxygen
nitrogen
speci
contribut
cellmedi
immunosuppress
complement
stimul
md
cell
also
prevent
activ
cell
inhibit
natur
killer
cell
cytotox
stimul
cytokin
product
tumorigenesi
increas
angiogenesi
complement
system
protein
provid
inflammatori
protect
tumor
microenviron
tumorassoci
antigen
known
modul
transmembran
signal
requir
prolifer
invas
metastasi
tumor
cell
presenc
nab
tumorassoci
antigen
gangliosid
melanoma
cell
correl
increas
patient
surviv
tumorreact
ab
exist
healthi
wildtyp
anim
blood
sampl
igm
peripher
blood
concentr
nab
increas
shortli
initi
tumor
develop
prior
detect
circul
antigen
nab
may
direct
cytotox
effect
tumor
cell
also
induc
bystand
effect
humor
antitumor
respons
thu
nab
recogn
tumormodifi
cell
surfac
develop
tumorigenesi
activ
complement
destroy
nascent
transform
cell
tumor
cell
abl
util
nab
escap
immunosurveil
neoplast
transform
alter
express
varieti
cell
surfac
glycoprotein
exampl
thomsenfriedenreich
antigen
disaccharid
gal
beta
galnac
alpha
truncat
glycosyl
express
elev
level
surfac
cancer
cell
abnorm
titer
correl
primari
carcinoma
cell
produc
nab
form
immunosurveil
cancer
cell
nab
induc
apoptosi
surfac
cell
tumor
cell
escap
abdepend
cytotox
releas
solubl
bind
nab
andnab
protect
tumor
cell
apoptosi
although
express
import
recognit
cancer
cell
solubl
secret
tumor
cell
prevent
ab
depend
elimin
tumor
cell
use
innat
immun
system
nab
avoid
immunosurveil
elimin
nab
import
recognit
elimin
precancer
cancer
cell
tumorreact
nab
express
multipl
tumor
type
includ
melanoma
lung
breast
head
neck
ovarian
cancer
exampl
human
monoclon
igm
ab
isol
gastric
cancer
patient
react
malign
tissu
induc
accumul
intracellular
lipid
cholesteryl
ester
triglycerid
humor
innat
immun
respons
nab
specif
import
role
recognit
elimin
neoplast
cell
nab
gener
tumor
surfac
antigen
autoab
produc
patient
bodi
respons
cancer
cell
format
util
detect
presenc
cancer
differenti
benign
malign
tumor
cell
surfac
glycan
secret
serum
malign
cell
provid
mechan
track
tumor
burden
mani
malign
cell
normal
cell
overexpress
ecfr
allow
protein
commonli
use
diagnost
marker
antigen
also
provid
therapeut
target
product
tumor
antigenspecif
monoclon
ab
human
cancer
known
produc
extracellular
proteolyt
enzym
requir
invas
dissemin
tumor
releas
proteolyt
enzym
breakdown
basement
membran
extracellular
matrix
ecm
facilit
cancercel
invas
surround
normal
tissu
regul
product
ecm
proteas
plasminogen
activ
pa
suggest
play
role
process
primari
pa
studi
relat
cancer
metastasi
urokinasetyp
upa
gener
plasmin
degrad
ecm
compar
normal
benign
tissu
malign
tumor
produc
elev
level
upa
upa
andor
receptor
upar
prognost
marker
human
malign
includ
breast
cancer
lung
cancer
oka
pedersen
bladder
cancer
bone
marrow
stomach
cancer
colorect
cervic
cancer
bind
upa
receptor
upar
appear
necessari
cancer
metastasi
compon
contact
system
upa
upar
level
correl
poor
prognosi
requir
success
invas
metastasi
upaplasmin
system
also
involv
cellular
process
tumorigenesi
includ
releas
growth
factor
exampl
bind
upa
upar
gener
plasmin
activ
latent
form
regul
cellular
function
includ
migrat
invas
cancer
cell
requir
chang
cadherin
integrin
express
bind
lead
alter
express
upa
upar
exampl
cancer
cell
detach
requir
downregul
ecadherin
express
increas
express
upa
invas
vitro
plasminogen
activ
ultim
activ
prekallikrein
kallikrein
gener
bradykinin
bradykinin
hydroxypropyl
hyp
bradykinin
elev
blood
plasma
periton
pleural
fluid
cancer
patient
bradykinin
potent
permeabl
factor
pain
induc
produc
tumor
microvasculatur
elev
bradykinin
mediat
enhanc
vascular
permeabl
allow
cell
invas
cancer
patient
also
upregul
human
rodent
cancer
tissu
kallikrein
cascad
also
implic
tumor
format
matsumura
et
al
show
continu
gener
kinin
stimul
prolifer
tumor
cell
mitogen
action
promot
diapedesi
enhanc
tumor
cell
metastasi
togeth
data
indic
contact
system
support
cell
migrat
invas
multipl
interact
upa
upar
kallikrein
kinin
ecm
protein
integrin
receptor
growth
factor
allow
reorgan
tumor
microenviron
short
pentraxin
famili
member
crp
synthes
liver
respons
stimul
increas
level
crp
observ
cancer
patient
exampl
crp
report
elev
metastat
breast
cancer
patient
mani
cancer
patient
also
elev
level
stimul
crp
product
serum
biomark
multipl
human
carcinoma
due
overexpress
cancer
tissu
includ
soft
tissu
liposarcoma
lung
carcinoma
breast
cancer
cell
line
overexpress
activ
antifibroblast
growth
factor
reduct
angiogenesi
vitro
vivo
experiment
clinic
data
suggest
humor
innat
immun
respons
initi
signific
protumor
effect
develop
neoplasia
humor
innat
immun
respons
exacerb
recruit
activ
immun
cell
tumor
microenviron
regul
tissu
remodel
proangiogen
prosurviv
pathway
potenti
cancer
format
thu
innat
immun
system
import
regul
cancer
develop
humor
immun
system
play
role
initi
regul
inflammatori
respons
elimin
pathogen
deriv
mani
small
plasma
protein
compon
innat
humor
immun
respons
disrupt
target
cell
plasma
membran
induc
cytolysi
togeth
humor
cellular
immun
respons
control
bacteri
viral
replic
elimin
infect
alter
cell
howev
pathogen
evolv
strategi
counter
evad
immun
respons
addit
humor
innat
respons
may
exploit
uncontrol
prolif
cancer
cell
atherosclerot
lesion
result
continu
expans
despit
humor
immun
respons
recogn
strategi
use
pathogen
alter
cell
allow
better
understand
patholog
interact
cell
infect
alter
host
wide
spectrum
humor
compon
activ
play
role
diseas
present
conclus
evid
humor
immun
system
modifi
cours
diseas
enhanc
pathogenesi
understand
relationship
pathogenesi
humor
immun
compon
enhanc
probabl
target
therapeut
treatment
patient
surviv
research
need
determin
mechan
action
interact
multipl
compon
humor
immun
well
role
pathogenesi
infect
neoplasia
atherosclerosi
regul
acquisit
erp
ospefrel
protein
factor
h
regul
acquisit
